Pallone: Bills Lowering Drug Prices Likely Will Be Limited To Medicare

By Rachel Cohrs / March 14, 2019 at 12:52 PM
House Energy & Commerce Committee Chair Frank Pallone (D-NJ) said Wednesday (March 13) that drug-pricing policy proposals that are likely to pass in Congress this session would benefit Medicare more than the commercial market. “Some people say, well what about everyone else? How are you going to bring costs down? I’m just talking realistically about what I think we can get signed into law and passed in both houses,” Pallone said at the America's Health Insurance Plans National Health Policy...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.